Monterey Bio Acquisition Corporation
MTRY · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Market Cap | $30 | $142 | $25 |
| - Cash | $0 | $1 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $30 | $141 | $25 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | -$2 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$2 | -$1 | $0 |
| % Margin | – | – | – |
| Net Income | -$1 | -$1 | -$0 |
| % Margin | – | – | – |
| EPS Diluted | -0.44 | -0.04 | -0 |
| % Growth | -989.1% | -4,208,233.3% | – |
| Operating Cash Flow | -$1 | -$1 | $0 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$1 | $0 |